Osvaldo Flores
Keine laufenden Positionen mehr
Vermögen: 4 Mio $ am 30.04.2024
Karriereverlauf von Osvaldo Flores
Ehemalige bekannte Positionen von Osvaldo Flores
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CENTURY THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - | 11.04.2023 |
Vorstandsvorsitzender | - | 11.04.2023 | |
Präsident | - | 11.04.2023 | |
Janssen, Inc. (Nebraska)
Janssen, Inc. (Nebraska) Miscellaneous Commercial ServicesCommercial Services Janssen, Inc. (Nebraska) is a private company based in Lincoln, NE. The company provides legal services. | Corporate Officer/Principal | 01.12.2015 | 01.12.2017 |
Novira Therapeutics LLC
Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Technik-/Wissenschafts-/F&E-Leiter | 22.03.2010 | 01.12.2015 |
Gründer | 01.01.2009 | 01.12.2015 | |
Präsident | 01.01.2009 | 01.12.2015 | |
Century Therapeutics, Inc. /Old/
Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Century Therapeutics, Inc. operates as a biotechnology company. It develops transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need. The company has created a allogeneic cell therapy platform that includes induced pluripotent stem cells, or iPSCs, differentiation know-how to generate immune effector cells from iPSCs, or iPSC-derived cells, clustered regularly interspaced short palindromic repeats, or CRISPR, mediated precision gene editing that allows it to incorporate multiple transgenes and remove target genes intended to optimize cell product performance, sophisticated protein engineering capabilities to develop proprietary next generation chimeric antigen receptors, or CARs, its proprietary Allo-EvasionTM technology intended to prevent rejection of its cell products by the host immune system, and cutting edge manufacturing capabilities intended to minimize product development and supply risk. Century Therapeutics was founded on March 5th, 2018 and is headquartered by Philadelphia, PA. | Direktor/Vorstandsmitglied | 01.01.2021 | - |
Vorstandsvorsitzender | 01.01.2021 | - | |
Präsident | 01.01.2021 | - |
Ausbildung von Osvaldo Flores
Rutgers State University of New Jersey | Doctorate Degree |
University of Medicine & Dentistry of New Jersey | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Frankreich | 2 |
Operativ
President | 3 |
Doctorate Degree | 2 |
Director/Board Member | 2 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CENTURY THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Novira Therapeutics LLC
Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Health Technology |
Century Therapeutics, Inc. /Old/
Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Century Therapeutics, Inc. operates as a biotechnology company. It develops transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need. The company has created a allogeneic cell therapy platform that includes induced pluripotent stem cells, or iPSCs, differentiation know-how to generate immune effector cells from iPSCs, or iPSC-derived cells, clustered regularly interspaced short palindromic repeats, or CRISPR, mediated precision gene editing that allows it to incorporate multiple transgenes and remove target genes intended to optimize cell product performance, sophisticated protein engineering capabilities to develop proprietary next generation chimeric antigen receptors, or CARs, its proprietary Allo-EvasionTM technology intended to prevent rejection of its cell products by the host immune system, and cutting edge manufacturing capabilities intended to minimize product development and supply risk. Century Therapeutics was founded on March 5th, 2018 and is headquartered by Philadelphia, PA. | Health Technology |
Janssen, Inc. (Nebraska)
Janssen, Inc. (Nebraska) Miscellaneous Commercial ServicesCommercial Services Janssen, Inc. (Nebraska) is a private company based in Lincoln, NE. The company provides legal services. | Commercial Services |
- Börse
- Insiders
- Osvaldo Flores
- Erfahrung